Brought to you by 
Cempra grosses $25mm via PIPE
29 Oct 2020
Executive Summary
Antibiotics developer Cempra Inc. has grossed $25.1mm through the private sale of 3.86mm common shares at $6.50 each (a 15% discount) to new and returning investors. Jefferies & Co., Cowen & Co., and Stifel Nicolaus & Co. were the placement agents.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cempra grosses $25mm via PIPE
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice